OMRIX Biopharmaceuticals clinical trials
Acquired by Johnson & Johnson, Dec 27, 2008 · source ↗
The registry lists 3 studies whose lead sponsor is OMRIX Biopharmaceuticals. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Dec 23, 2009.
Before and after it joined Johnson & Johnson
- First submitted before OMRIX Biopharmaceuticals became part of Johnson & Johnson
- 2
- First submitted after OMRIX Biopharmaceuticals became part of Johnson & Johnson
- 1
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Status
- Status unknown
- 1
- Suspended
- 1
- Completed
- 1
Registry sponsor names on this page
- OMRIX Biopharmaceuticals3 studies
Something wrong with this grouping? Tell us on the Johnson & Johnson page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Johnson & Johnson studies →
- Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological SurgerySuspendedNCT00865488Phase 3
Sponsor listed in the registry: OMRIX Biopharmaceuticals · First submitted after OMRIX Biopharmaceuticals became part of Johnson & Johnson
- Safety and Hemostatic Efficacy of Fibrin Fleece in Partial NephrectomyCompletedNCT00598130Phase 2
Sponsor listed in the registry: OMRIX Biopharmaceuticals · First submitted before OMRIX Biopharmaceuticals became part of Johnson & Johnson
- Pilot Study Evaluating the Safety and Potential Trends in Efficacy of AdhexilStatus unknownNCT00544310Phase 1/2
Sponsor listed in the registry: OMRIX Biopharmaceuticals · First submitted before OMRIX Biopharmaceuticals became part of Johnson & Johnson